Artificial pancreatic perfusion device

• US 5,002,661 A
• Filed: 08/25/1989
• Issued: 03/26/1991
• Est. Priority Date: 08/25/1989
• Status: Expired due to Term

• Current Assignee: CB Biomedical, Inc. (Arbios Systems, Inc.)
• Original Assignee: W R Grace & Company - CONN (WR Grace & Company)
• Inventors: Solomon, Barry A., Doherty, Edward J., Harvey, John M., Borland, Kermit M., Foley, Amy L., King, Donald P. Jr., Muller, Thomas E., Sullivan, Susan J., Dunleavy, Karen E., Chick, William L.
• Primary Examiner(s): Jones, W. Gary
• Application Number:
  US07/398,739
• Time in Patent Office: 578 Days
• Field of Search: 210/192, 210/321.78, 210/321.87, 210/321.79, 210/321.88, 210/321.8, 210/321.89, 210/209, 210/198.1, 604/4, 604/175, 435/283, 435/284, 435/285, 435/286, 424/424, 424/101
• US Class Current: 210/192
• CPC Class Codes: A61F 2/022 Artificial gland structures using bioreactors hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36
• CPC Class Codes: A61L 27/04 Metals or alloys
• CPC Class Codes: A61L 27/14 Macromolecular materials
• CPC Class Codes: A61M 1/1678 intracorporal peritoneal dialysis A61M1/28
• CPC Class Codes: A61M 1/3472 with treatment of the filtrate
• CPC Class Codes: A61M 1/3475 with filtrate treatment agent in the same enclosure as the membrane

Abstract

A device which serves as an artificial pancreas comprises a hollow fiber having an inner diameter of about 5 mm which is surrounded by islets of Langerhans enclosed in a housing. The islets are suspended in a semi-solid matrix which ensures desired distribution of the cells about the hollow fiber. The hollow fiber and suspended islets are enclosed in a housing which further aids the desired distribution of islets about the hollow fiber. The hollow fiber has a porosity which selectively allows passage of substances having a molecular weight of less than about 100,000 Daltons. The semi-solid matrix in which the islets are embedded and suspended is formed of an appropriate supporting material such as alginate or agar.

Claims

1. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the hollow fiber having a porosity which selectively allows substances to pass transversely therethrough, such that blood flows within the hollow fiber, along the length of the fiber; and

(b) a housing containing a suspension of pancreatic islets of Langerhans, the suspension including pancreatic islets distributed in an appropriate supporting material about the hollow fiber such that the hollow fiber is surrounded by pancreatic islets along its length, the supporting material maintaining distribution and desired location of the islets with respect to the hollow fiber.

2. An artificial pancreatic perfusion device as in claim 1, wherein the hollow fiber has a porosity which allows for passage only of substances of molecular weight of less than 100,000 Daltons.

3. An artificial pancreatic perfusion device as in claim 1 wherein the supporting material is distributed circumferentially and longitudinally about the hollow fiber.

4. An artificial pancreatic perfusion device as in claim 1, wherein the supporting material comprises a semi-solid matrix for suspending islets, the semi-solid matrix being positioned about the hollow fiber to surround the fiber.

5. An artificial pancreatic perfusion device as in claim 1 wherein the supporting material is introduced to the hollow fiber in a liquid form and maintained under appropriate conditions to form a semi-solid matrix.

6. An artificial pancreatic perfusion device as in claim 5 wherein said supporting material comprises agar or alginate.

7. An artificial pancreatic perfusion device as in claim 1 wherein the housing encloses the hollow fiber in a spaced apart manner, such that the housing defines a chamber circumferentially about the hollow fiber along the length of the fiber, the housing being positioned sufficiently close to the fiber along the length of the fiber to maximize diffusion across the fiber wall.

8. An artificial pancreatic perfusion device as in claim 7 wherein the housing is cylindrical in shape and the hollow fiber is coaxially positioned therein.

9. An artificial pancreatic perfusion device as in claim 7 wherein:

(a) the housing is annular in shape about a central axis; and

(b) the hollow fiber is coiled about the central axis and lies within the housing in a manner spaced apart from inner walls of the housing, each loop of the coiled fiber being spaced apart from succeeding and preceding loops.

10. An artificial pancreatic perfusion device as in claim 9 further comprising spacers between successive loops of the coiled fiber to maintain the loops in a spaced apart manner.

11. An artificial pancreatic perfusion device as in claim 7 wherein the housing is a coiled tube and the hollow fiber is coaxially positioned therein.

12. An artificial pancreatic perfusion device as in claim 1 wherein the connecting means comprises vascular graft material.

13. An artificial pancreatic perfusion device as in claim 1 wherein the connecting means comprises a butt joint.

14. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting mean to return blood to the individual, the blood flowing within the fiber along the length of the fiber, the fiber having a porosity which selectively allows substances to pass transversely therethrough; and

(b) a housing containing a suspension of pancreatic islets of Langerhans, the suspension including pancreatic islets distributed in an appropriate supporting material about the hollow fiber in a manner which maximizes diffusion of substances from the blood within the fiber, transversely across the hollow fiber wall to the islets to stimulate generation of insulin by the islets, and maximizes passage of generated insulin transversely through the fiber wall and into the blood flowing within the fiber, the supporting material maintaining distribution and desired location of the pancreatic islets with respect to the hollow fiber.

15. An artificial pancreatic perfusion device as in claim 14 wherein the housing positions pancreatic islets circumferentially and longitudinally about the hollow fiber such that the fiber is surrounded by pancreatic islets along its length.

16. An artificial pancreatic perfusion device as in claim 14 wherein the supporting material comprises a semi-solid matrix for suspending islets, the semi-solid matrix being distributed circumferentially about the hollow fiber along the length of the fiber.

17. An artificial pancreatic perfusion device as in claim 14 wherein the housing encloses the hollow fiber in a spaced apart manner such that the housing defines a chamber circumferentially about the fiber along the length of the fiber, the housing being sufficiently close to the fiber along the length of the fiber to maximize diffusion.

18. An artificial pancreatic perfusion device as in claim 17 wherein the housing is cylindrical in shape and the hollow fiber is coaxially positioned therein.

19. An artificial pancreatic perfusion device as in claim 17 wherein:

(a) the housing is annular in shape about a central axis; and

(b) the hollow fiber is coiled about the central axis and lies within the housing in a manner spaced apart from inner walls of the housing, each loop of the coiled fiber being spaced apart from succeeding and preceding loops.

20. An artificial pancreatic perfusion device as in claim 19 further comprising spacers between successive loops of the coiled fiber to maintain the loops spaced apart.

21. An artificial pancreatic perfusion device as in claim 17 wherein the housing is a coiled tube and the hollow fiber is coaxially position therein.

22. A method of seeding an artificial organ with islets of Langerhans comprising:

(a) suspending the islets in a solution consisting essentially of nutrient medium and liquified agar to thereby form an islet suspension;

(b) injecting said suspension into said artificial organ; and

(c) solidifying the islet suspension to thereby form a semi-solid matrix maintaining distribution and desired location of the islet cells within the housing.

23. A method of claim 22 wherein the suspension is injected by creation of negative pressure to pull islet suspension into the artificial organ.

24. A method of claim 22 wherein additional components are added to the nutrient medium to enhance islet viability, said components selected from the group consisting of:

collagen, laminin and growth factors.

25. A method of claim 22 wherein the islet suspension is co-cultured with cells which enhance graft biocompatibility and islet viability, said cells selected from the group consisting of:

endothelial cells, fibroblasts and cells which produce growth factors or basement membrane.

26. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) an annular shaped, plastic housing;

(b) a hollow fiber coiled within the housing and spaced apart from inner walls of the housing, the hollow fiber having opposite ends adapted to be coupled to a blood vessel such that the hollow fiber through one end receives blood from the individual, the blood flows within the fiber, along the length of the fiber, and through the opposite end of the fiber supplies flowing blood to the individual, the hollow fiber having a porosity which selectively allows passage of substances transversely through the fiber wall, and having a total inner surface area adequate to support the number of islets required for insulin secretion; and

(c) a pancreatic islet suspension including pancreatic islets distributed in an appropriate supporting material about the hollow fiber, the islet suspension surrounding the hollow fiber within the housing, and the supporting material maintaining distribution and desired location of the islets with respect to the hollow fiber, and islets within the suspension generating insulin which diffuses across the hollow fiber wall to the blood flowing within the hollow fiber in response to substances diffused across the hollow fiber wall from the blood.

27. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the hollow fiber having an inner diameter substantially matching an inner diameter of the blood vessel connected thereto and having a porosity which selectively allows substances to pass transversely therethrough, such that blood flows within the hollow fiber, along the length of the fiber; and

(b) a housing containing pancreatic islets of Langerhans distributed in an appropriate supporting material about the hollow fiber such that the hollow fiber is surrounded by pancreatic islets along its length,

wherein the housing is annular in shape about a central axis and encloses the hollow fiber in a spaced apart manner, such that the housing defines a chamber circumferentially about the hollow fiber along the length of the fiber, the housing is positioned sufficiently close to the fiber along the length of the fiber to maximize diffusion across the fiber wall, and the hollow fiber is coiled about the central axis and lies within the housing in a manner spaced apart from the inner walls of the housing, each loop of the coiled fiber being spaced apart from succeeding and preceding loops.

28. An artificial pancreatic perfusion device as in claim 27 further comprising spacers between successive loops of the coiled fiber to maintain the loops in a spaced apart manner.

29. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the hollow fiber having an inner diameter substantially matching an inner diameter of the blood vessel connected thereto and having a porosity which selectively allows substances to pass transversely therethrough, such that blood flows within the hollow fiber, along the length of the fiber; and

(b) a housing containing pancreatic islets of Langerhans distributed in an appropriate supporting material about the hollow fiber, such that the hollow fiber is surrounded by pancreatic islets along its length,

wherein the housing is a coiled tube and the hollow fiber is coaxially positioned therein and the housing encloses the hollow fiber in a spaced apart manner, such that the housing defines a chamber circumferentially about the hollow fiber along the length of the fiber, the housing is positioned sufficiently close to the fiber along the length of the fiber to maximize diffusion across the fiber wall, and the hollow fiber is coiled about the central axis and lies within the housing in a manner spaced apart from the inner walls of the housing, each loop of the coiled fiber being spaced apart from succeeding and preceding loops.

30. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the blood flowing within the fiber along the length of the fiber, the fiber having a porosity which selectively allows substances to pass transversely therethrough; and

(b) a housing containing pancreatic islets of Langerhans distributed in an appropriate supporting material about the hollow fiber in a manner which maximizes diffusion of substances from the blood within the fiber, transversely across the hollow fiber wall to the islets to stimulate generation of insulin by the islets, and maximizes passage of generated insulin transversely through the fiber wall and into the blood flowing within the fiber,

wherein the housing is annular in shape about a central axis and encloses the hollow fiber in a spaced apart manner such that the housing defines a chamber circumferentially about the fiber along the length of the fiber, the housing is sufficiently close to the fiber along the length of the fiber to maximize diffusion, and the hollow fiber is coiled about the central axis and lies within the housing in a manner spaced apart from inner walls of the housing, each loop of the coiled fiber being spaced apart from succeeding and preceding loops.

31. An artificial pancreatic perfusion device as in claim 30 further comprising spacers between successive loops of the coiled fiber to maintain the loops in a spaced apart manner.

32. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the blood flowing within the fiber along the length of the fiber, the fiber having a porosity which selectively allows substances to pass transversely therethrough; and

(b) a housing containing pancreatic islets of Langerhans distributed in an appropriate supporting material about the hollow fiber in a manner which maximizes diffusion of substances from the blood within the fiber, transversely across the hollow fiber wall to the islets to stimulate generation of insulin by the islets, and maximizes passage of generated insulin transversely through the fiber wall and into the blood flowing within the fiber,

wherein the housing is a coiled tube and the hollow fiber is coaxially positioned therein, and the housing encloses the hollow fiber in a spaced apart manner such that the housing defines a chamber circumferentially about the fiber along the length of the fiber, the housing being sufficiently close to the fiber along the length of the fiber to maximize diffusion.

33. An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising:

(a) a housing;

(b) a hollow fiber coiled within the housing and spaced apart from inner walls of the housing, the hollow fiber having opposite ends adapted to be coupled to a blood vessel such that the hollow fiber through one end receives blood from the individual, the blood flows within the fiber, along the length of the fiber, and through the opposite end of the fiber supplies flowing blood to the individual, the hollow fiber having a porosity which selectively allows passage of substances transversely through the fiber wall, and having a total inner surface area adequate to support the number of islets required for insulin secretion; and

(c) a pancreatic islet suspension including pancreatic islets distributed in an appropriate supporting material about the hollow fiber, the supporting material maintaining distribution and desired location of the islets with respect to the hollow fiber, the islet suspension surrounding the hollow fiber within the housing, islets within the suspension generating insulin which diffuses across the hollow fiber wall to the blood flowing within the hollow fiber in response to substances diffused across the hollow fiber wall from the blood.